Chinese pharma app seals $133m series D funding

Pharmaceutical trading platforms like Yaoshibang help stores in dispersed and remote cities to meet the increasing demand of patients.

Chinese pharma app seals $133m series D funding

Chinese B2B pharmaceutical trading platform Yaoshibang has completed its $133 million Series D fundraising on Monday.

Tiger Global, H Capital and DCM Ventures all participated.

Proceeds will be used to hire more talent and to improve platform security.

Yaoshibang is a B2B platform which connects pharmaceutical companies, drug stores and clinics. It sells medicines wholesale together with software services so that chemists can track purchases. Launched in...

FinanceAsia has updated its subscription model. Registered readers now have the opportunity to read five articles from our award-winning website for free. Please subscribe for unlimited access.

Print Edition

FinanceAsia Print Edition